| # | Drug | Count |
|---|---|---|
| 0 | TOFACITINIB | 1522 |
| 1 | OMALIZUMAB | 792 |
| 2 | PREDNISONE | 758 |
| 3 | METHOTREXATE SODIUM | 734 |
| 4 | ADALIMUMAB | 720 |
| 5 | METHOTREXATE | 616 |
| 6 | ETANERCEPT | 609 |
| 7 | ALBUTEROL SULFATE | 530 |
| 8 | DUPILUMAB | 354 |
| 9 | MONTELUKAST SODIUM | 344 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPROPION HYDROBROMIDE | 21 | 0.0364 |
| 1 | INFLIXIMAB-DYYB | 43 | 0.0125 |
| 2 | GOLD | 57 | 0.0098 |
| 3 | OMALIZUMAB | 792 | 0.0091 |
| 4 | REPOSITORY CORTICOTROPIN | 40 | 0.0090 |
| 5 | ERGOCALCIFEROL | 217 | 0.0073 |
| 6 | CICLESONIDE | 94 | 0.0068 |
| 7 | GLYCOPYRROLATE | 37 | 0.0065 |
| 8 | ANAKINRA | 84 | 0.0050 |
| 9 | C1 ESTERASE INHIBITOR RECOMBINANT | 26 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1014 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 797 |
| 2 | Anti-IgE [EPC] | 792 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 672 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 613 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 354 |
| 6 | Vitamin C [EPC] | 299 |
| 7 | Antirheumatic Agent [EPC] | 297 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 258 |
| 9 | Vitamin B12 [EPC] | 255 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 40 | 0.0447 |
| 1 | Interleukin-5 Antagonist [EPC] | 28 | 0.0407 |
| 2 | Anti-IgE [EPC] | 792 | 0.0091 |
| 3 | Cortisol Synthesis Inhibitor [EPC] | 6 | 0.0079 |
| 4 | Provitamin D2 Compound [EPC] | 217 | 0.0073 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 84 | 0.0050 |
| 6 | Interleukin-17A Antagonist [EPC] | 124 | 0.0033 |
| 7 | Plasma Kallikrein Inhibitor [EPC] | 7 | 0.0029 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 9 | Antirheumatic Agent [EPC] | 297 | 0.0028 |